ASTRAZENECA PHARMA Fact Sheet, ASTRAZENECA PHARMA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA Fact Sheet    (AIDL)


Revealed: How to Get Rich with Just 3 Stocks


Here is the latest financial fact sheet of ASTRAZENECA PHARMA. For more details, see the ASTRAZENECA PHARMA quarterly results and ASTRAZENECA PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

ASTRAZENECA PHARMA Price History

Price Rs 3,331.8
Mkt Cap Rs m 83,295
Vol '000 1.6
P/E X 115.3
P/CF X 204.9
EPS (TTM) Rs 28.9
% ch % -0.2
No. of shares m 25.00
% ch week % -0.1
% ch 1-mth % -5.3
% ch 12-mth % 70.3
52 week H/L Rs 3,700.0/1,635.3
(As on Aug 7, 2020 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ASTRAZENECA PHARMA Financials

No. of Mths
Year Ending
12
Mar-14
12
Mar-15
12
Mar-16
12
Mar-17
12
Mar-18
5-Yr Chart
Click to enlarge
ASTRAZENECA PHARMA EQUITY SHARE DATA
High Rs1,2851,2451,3481,2151,278 
Low Rs634785850909883 
Sales per share (Unadj.) Rs189.6187.2206.7217.5228.4 
Earnings per share (Unadj.) Rs-0.2-8.32.18.010.4 
Diluted earnings per shareRs-0.2-8.32.18.010.4 
Cash flow per share (Unadj.) Rs3.8-2.29.114.416.3 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Dividend yield (eoy) %00000 
Book value per share (Unadj.) Rs68.660.362.489.198.8 
Adj. book value per shareRs68.660.362.489.198.8 
Shares outstanding (eoy) m25.0025.0025.0025.0025.00 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x5.15.45.34.94.7 
Avg P/E ratio x-4,712.7-121.8522.3132.4104.2 
P/CF ratio (eoy) x249.6-456.5121.174.066.4 
Price / Book Value ratio x14.016.817.611.910.9 
Dividend payout %00000 
Avg Mkt Cap Rs m23,98825,37927,47526,55027,008 
No. of employees `0001.61.71.61.11.4 
Total wages/salary Rs m1,6051,5981,6941,6201,535 
Avg. sales/employee Rs Th3,040.22,830.33,256.24,765.24,210.9 
Avg. wages/employee Rs Th1,029.2966.41,067.11,420.21,132.2 
Avg. net profit/employee Rs Th-3.3-126.033.1175.7191.1 
ASTRAZENECA PHARMA INCOME DATA
Net Sales Rs m4,7404,6815,1685,4375,710 
Other income Rs m925968144123 
Total revenues Rs m4,8324,7405,2355,5815,833 
Gross profit Rs m-130-114164369463 
Depreciation Rs m101153174158147 
Interest Rs m00000 
Profit before tax Rs m-139-20858355438 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m1390000 
Tax Rs m505155179 
Profit after tax Rs m-5-20853201259 
Gross profit margin %-2.7-2.43.26.88.1 
Effective tax rate %-3.708.743.540.8 
Net profit margin %-0.1-4.51.03.74.5 
ASTRAZENECA PHARMA BALANCE SHEET DATA
Current assets Rs m2,7262,6332,6582,5163,209 
Current liabilities Rs m2,4352,5982,4311,9032,070 
Net working cap to sales %6.10.74.411.320.0 
Current ratio x1.11.01.11.31.6 
Inventory Days Days7467543972 
Debtors Days Days4133582935 
Net fixed assets Rs m1,0351,1321,037917790 
Share capital Rs m5050505050 
"Free" reserves Rs m9421,4581,5102,1792,419 
Net worth Rs m1,7161,5081,5602,2292,469 
Long term debt Rs m00000 
Total assets Rs m4,1564,1164,4874,1554,605 
Interest coverage xNMNMNMNMNM 
Debt to equity ratio x00000 
Sales to assets ratio x1.11.11.21.31.2 
Return on assets %-0.1-5.11.24.85.6 
Return on equity %-0.3-13.83.49.010.5 
Return on capital %0-13.83.715.917.7 
Exports to sales %5.70.5000 
Imports to sales %6.52.33.200 
Exports (fob) Rs m27024000 
Imports (cif) Rs m30610816400 
Fx inflow Rs m3753397216300 
Fx outflow Rs m4701,1191,2221,3242,015 
Net fx Rs m-96-1,086-1,125-1,107-1,715 
ASTRAZENECA PHARMA CASH FLOW
From Operations Rs m -8 -457 570 381 88 
From Investments Rs m -146 -186 -36 3 -94 
From Financial Activity Rs m 862 0 -5 0 0 
Net Cashflow Rs m 709 -644 529 384 -6 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 0.0%
Foreign collaborators 75.0%
Indian inst/Mut Fund 0.3%
FIIs 15.7%
ADR/GDR 0.0%
Free float 9.1%
Shareholders 12,856
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 'Avishkar', Off Bellary Road, Hebbal, Bangalore - 560 024
E-MAIL comp.secy@astrazeneca.com WEB www.astrazenecaindia.com
TELEPHONE (080) 6774 8000 FAX (080) 2362 2015
SECTOR PHARMACEUTICALS GROUP M N C
TR AGENT Integrated Enterp., Ramana Residency, 4th Cross, Malleswaram, Bangalore-03
AUDITOR BSR & Co.
CHM: D. E. Udwadia COMP SEC: Anantha Murthy YEAR OF INC: 1900 BSE CODE: 506820 FV (Rs): 2 DIV YIELD (%): -

Read: ASTRAZENECA PHARMA 2017-18 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   DISHMAN PHARMA  BIOCON   VENUS REMEDIES  FRESENIUS KABI ONCO.  AUROBINDO PHARMA  

Compare ASTRAZENECA PHARMA With:   DISHMAN PHARMA  BIOCON   VENUS REMEDIES  FRESENIUS KABI ONCO.  AUROBINDO PHARMA  

Compare ASTRAZENECA PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Flat; Power and Telecom Stocks Witness Buying(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Views on news

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 2.5% (Quarterly Result Update)

May 20, 2020 | Updated on May 20, 2020

For the quarter ended March 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 96 m (down 2.5% YoY). Sales on the other hand came in at Rs 2 bn (up 2.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 236.5% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 215 m (up 236.5% YoY). Sales on the other hand came in at Rs 2 bn (up 26.7% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Mar 29, 2019 | Updated on Mar 29, 2019

Here's an analysis of the annual report of ASTRAZENECA PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ASTRAZENECA PHARMA. Also includes updates on the valuation of ASTRAZENECA PHARMA.

More Views on News

Most Popular

These 5 Smallcaps Deserve a Place in Your Coffee Can Portfolio (Profit Hunter)

Jul 28, 2020

When it comes to quality stocks, doing less is more.

Before You Buy Your First Electric Vehicle Consider Buying this Stock (Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

How to Buy Gold and Silver (Fast Profits Daily)

Jul 27, 2020

In this video I'll show you how to buy bullion the right way.

Elon Musk Gives Us a Trading Opportunity (Fast Profits Daily)

Jul 28, 2020

Elon Musk made a statement recently which I believe, gives us a fast profit trading opportunity.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

TRACK ASTRAZENECA PHARMA

  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASTRAZENECA PHARMA

ASTRAZENECA PHARMA - SUVEN LIFESCIENCES COMPARISON

COMPARE ASTRAZENECA PHARMA WITH

MARKET STATS